This article was first published in Managing Intellectual Property, June 2016
Genomic technology has rapidly created a multi¬billion dollar growth industry . With life sciences companies scrambling in US and European courts for a share of the lucrative market, inhouse IP counsel should start preparing for the next wave of IP litigation, explain Dominic Adair and Annsley Merelle Ward.
On a late June morning in 2000, US President Bill Clinton walked down the red carpet in the White House’s East Room towards the presidential podium facing a wall of impatient reporters. Linked by satellite to UK Prime Minister Tony Blair, President Clinton announced the news that the first map of the human genome was complete. As one of humankind’s greatest scientific achievements, President Clinton predicted that genome science would “revolutionize the diagnosis, prevention and treatment of most, if not all, human diseases”. Now, almost 20 years later, it has….
To read the full article, please click HERE (subscription only).